Iveric Bio Inc (NASDAQ:ISEE)
| 13.93 BATS BZX Real-Time Price As of 3:06pm ET |  -0.89 / -6.01%Today’s Change | 4.96 Today|||52-Week Range 19.32 | +101.59% Year-to-Date |
Latest ISEE News | Press Releases
| Vertex (VRTX) Up on Kidney Disease Drug's Success in Phase II Dec 02 / Zacks.com - Paid Partner Content | Novavax (NVAX) Stock Up YTD on COVID-19 Vaccine Potential Nov 29 / Zacks.com - Paid Partner Content |
| AbbVie (ABBV) Files for Skyrizi to Treat Crohn's Disease in EU Dec 01 / Zacks.com - Paid Partner Content | Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval Nov 25 / Zacks.com - Paid Partner Content |
| Jazz (JAZZ) Begins Zepzelca Combo Study for First-Line SCLC Dec 01 / Zacks.com - Paid Partner Content | Amryt (AMYT) Skin Disorder NDA Review Gets 3 Months Extension Nov 24 / Zacks.com - Paid Partner Content |
| Adagene (ADAG) Gets FDA Nod to Begin Solid Tumor Antibody Study Nov 30 / Zacks.com - Paid Partner Content | BioMarin's (BMRN) Dwarfism Drug Gets FDA's Nod, Stock Up Nov 22 / Zacks.com - Paid Partner Content |
| Commodore Capital Lp Buys Dicerna Pharmaceuticals Inc, IVERIC bio Inc, Merus NV, Sells , ... Nov 29 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 14.82 |
| Today’s open | 14.00 |
| Day’s range | 13.89 - 14.93 |
| Volume | 67,456 |
| Average volume (3 months) | 3,910,704 |
| Market cap | $1.8B |
Data as of 3:06pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | +18.24% |
| Earnings growth (this year) | +6.44% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 7.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ENTAEnanta Pharmaceutica... | -1.05 | -1.25% |
| HSKAHeska Corp | -3.12 | -1.95% |
| VCELVericel Corp | +0.01 | +0.03% |
| SUPNSupernus Pharmaceuti... | -1.09 | -3.50% |
Data as of 3:05pm ET, 12/03/2021
Financials
| Next reporting date | March 1, 2022 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$84.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
